Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague
When it comes to the pharmaceutical industry, weight-loss medications are all the rage right now. While Ozempic maker Novo Nordisk dominates medications designed to treat obesity and diabetes, two other companies are looking to get their slice of the pie -- but only one is succeeding. Let's break…
#novonordisk #elililly #lly #mounjaro #fda #ozempic #zepbound #pfe #pfizer #seagen